Understanding how immune cells in the pancreas affect diabetes
Regulation of GPCR-mediated intercellular communication in islets
This study is looking at how certain immune cells affect inflammation in the pancreas and how that might impact insulin production, especially in mice on a high-fat diet, to help find better ways to manage diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11059251 on NIH RePORTER |
What this research studies
This research investigates the role of immune cells, specifically macrophages, in the inflammation of pancreatic islets and how this inflammation impacts the function of insulin-producing beta cells. By studying mice that are fed a high-fat diet, the researchers aim to understand how a specific receptor, GPR92, influences these immune cells and their interaction with beta cells. The study employs advanced techniques such as computer simulations and genetic modifications to explore these relationships, which could lead to new insights into diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with obesity and adult-onset diabetes who may benefit from improved understanding and treatment of their condition.
Not a fit: Patients without obesity or those with type 1 diabetes may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve insulin production and function in patients with obesity-related diabetes.
How similar studies have performed: Previous research has shown promising results in understanding immune cell roles in diabetes, but the specific focus on GPR92 in this context is relatively novel.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Oh, Dayoung — Ut Southwestern Medical Center
- Study coordinator: Oh, Dayoung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.